Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael W Graner

Showing results (21-30 of 76) with videos related to

Pageof 8
Sort By:
International Journal of Cancer|April 8, 2004
Imatinib mesylate effectively combines with chaperone-rich cell lysate-loaded dendritic cells to treat bcr-abl+ murine leukemiaYi Zeng, Michael W Graner, Hanping Feng, et al.
Journal of Biomedicine & Biotechnology|May 5, 2004
Evidence for a Novel, Caspase-8-Independent, Fas Death Domain-Mediated Apoptotic PathwayHanping Feng, Yi Zeng, Michael W. Graner, et al.
Blood|October 24, 2002
Exogenous stress proteins enhance the immunogenicity of apoptotic tumor cells and stimulate antitumor immunityHanping Feng, Yi Zeng, Michael W Graner, et al.
Cancer Science|August 8, 2009
Heat shock protein 70-binding protein 1 is highly expressed in high-grade gliomas, interacts with multiple heat shock protein 70 family members, and specifically binds brain tumor cell surfacesMichael W Graner, Deborah A Raynes, Darell D Bigner, et al.
Biochemical and Biophysical Research Communications|September 2, 2024
Possible regulation of the immune modulator tetraspanin CD81 by alpha-synuclein in melanomaNirjhar M Aloy, Christina Coughlan, Michael W Graner, et al.
Journal of Pharmaceutical Sciences|November 24, 2018
The Potential of Exosomes From Cow Milk for Oral DeliveryJamie L Betker, Brittany M Angle, Michael W Graner, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 9, 2004
Increased expression of the Hsp70 cochaperone HspBP1 in tumorsDeborah A Raynes, Michael W Graner, Rochelle Bagatell, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|June 6, 2013
Proteomic analyses of different human tumour-derived chaperone-rich cell lysate (CRCL) anti-cancer vaccines reveal antigen content and strong similarities amongst the vaccines along with a basis for CRCL's unique structure: CRCL vaccine proteome leads to unique structureTehila Mayer-Sonnenfeld, Michael Har-Noy, Kevin O Lillehei, et al.
Biochimica Et Biophysica Acta|August 8, 2014
Examination of the specificity of tumor cell derived exosomes with tumor cells in vitroTyson J Smyth, Jasmina S Redzic, Michael W Graner, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 1, 2006
Peritransplantation vaccination with chaperone-rich cell lysate induces antileukemia immunityXinchun Chen, Yi Zeng, Gang Li, et al.
Pageof 8

Showing results (21-30 of 76) with videos related to

Sort By:
Pageof 8
International Journal of Cancer|April 8, 2004
Imatinib mesylate effectively combines with chaperone-rich cell lysate-loaded dendritic cells to treat bcr-abl+ murine leukemiaYi Zeng, Michael W Graner, Hanping Feng, et al.
Journal of Biomedicine & Biotechnology|May 5, 2004
Evidence for a Novel, Caspase-8-Independent, Fas Death Domain-Mediated Apoptotic PathwayHanping Feng, Yi Zeng, Michael W. Graner, et al.
Blood|October 24, 2002
Exogenous stress proteins enhance the immunogenicity of apoptotic tumor cells and stimulate antitumor immunityHanping Feng, Yi Zeng, Michael W Graner, et al.
Cancer Science|August 8, 2009
Heat shock protein 70-binding protein 1 is highly expressed in high-grade gliomas, interacts with multiple heat shock protein 70 family members, and specifically binds brain tumor cell surfacesMichael W Graner, Deborah A Raynes, Darell D Bigner, et al.
Biochemical and Biophysical Research Communications|September 2, 2024
Possible regulation of the immune modulator tetraspanin CD81 by alpha-synuclein in melanomaNirjhar M Aloy, Christina Coughlan, Michael W Graner, et al.
Journal of Pharmaceutical Sciences|November 24, 2018
The Potential of Exosomes From Cow Milk for Oral DeliveryJamie L Betker, Brittany M Angle, Michael W Graner, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 9, 2004
Increased expression of the Hsp70 cochaperone HspBP1 in tumorsDeborah A Raynes, Michael W Graner, Rochelle Bagatell, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|June 6, 2013
Proteomic analyses of different human tumour-derived chaperone-rich cell lysate (CRCL) anti-cancer vaccines reveal antigen content and strong similarities amongst the vaccines along with a basis for CRCL's unique structure: CRCL vaccine proteome leads to unique structureTehila Mayer-Sonnenfeld, Michael Har-Noy, Kevin O Lillehei, et al.
Biochimica Et Biophysica Acta|August 8, 2014
Examination of the specificity of tumor cell derived exosomes with tumor cells in vitroTyson J Smyth, Jasmina S Redzic, Michael W Graner, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 1, 2006
Peritransplantation vaccination with chaperone-rich cell lysate induces antileukemia immunityXinchun Chen, Yi Zeng, Gang Li, et al.
Pageof 8